Resonance Health Appoints New Distributor, KNS in Canada
- 24 September 2015
Resonance Health is pleased to announce the appointment of KNS in Canada who will launch a local presence for FerriScan at the forthcoming 2015 Pan-Canadian Thalassemia Conference taking place in Toronto on September 25-26th.
St Mary’s Hospital Celebrates 1000 FerriScans From Perth to Paddington!
- 23 September 2015
St Mary’s Hospital has become one of the first hospitals in Europe to reach a milestone of providing 1000 FerriScans (the Gold Standard for measuring Liver Iron Concentration) for children and adult patients.
HEPAFAT-SCAN® FATTY LIVER STUDY COMMENCES IN THE USA
- 21 August 2015
We are excited to announce that the paediatric fatty liver disease study using HepaFat-Scan has now commenced in the USA. It is being run in collaboration with the prestigious children’s hospital, Children’s Healthcare of Atlanta. At the date of this release, approximately ten patients have already been recruited and had HepaFat-Scans completed for the study, which commenced last month.
Entrepreneur of the Year Award - Western Region Technology Winner!
- 29 July 2015
Congratulations to our Chief Scientific Officer, Professor Tim St Pierre, for winning the Technology category of the Western Region EY Entrepreneur of the Year™ award on behalf of Resonance Health!
Conference Update: China Symposium on NAFLD in Shanghai
- 23 July 2015
The symposia on Non-alcoholic Fatty Liver Disease (NAFLD) in Shanghai was co-organised by the China Medical Association and Zhongshan Hospital Fudan University, chaired by Prof Gao Xin.
Conference Update: Showcasing Resonance Health in Europe
- 14 July 2015
Resonance Health attended or exhibited at three conferences in Europe in June 2015. We profiled both our FerriScan® and HepaFat-Scan® technologies to thousands of delegates and generated almost a hundred leads from around the world.